Related Experiment Videos
[Combination aerosol for bronchial asthma in childhood]
Insights
This study found that a combination aerosol of Fenoterol and Ipratropium significantly reduced asthma attacks in children. The treatment also improved lung function and ventilation within minutes of administration.
Area of Science:
- Pediatrics
- Pulmonology
- Pharmacology
Context:
- Bronchial asthma is a common chronic respiratory disease in children.
- Allergic disposition is frequently associated with childhood asthma.
- Evaluating the efficacy of combination inhalers is crucial for asthma management.
Purpose:
- To investigate the therapeutic and protective effects of a Fenoterol and Ipratropium combination aerosol in children with bronchial asthma.
- To assess the impact on asthma attack frequency, pulmonary auscultation, and lung function parameters.
Summary:
- Forty children (aged 8-14) with diagnosed bronchial asthma, most with allergic disposition, participated in the study.
- Combination aerosol therapy with Fenoterol and Ipratropium led to a nearly 50% reduction in asthma attacks over 4 weeks.
- Significant improvements in pulmonary ventilation were observed 10 and 20 minutes post-inhalation, with modest effects noted for severe cases using Berodual alone.
Impact:
- Provides evidence for the effectiveness of Fenoterol/Ipratropium combination therapy in pediatric asthma.
- Highlights the rapid onset of action for improving lung function in asthmatic children.
- Suggests Berodual monotherapy may have limited benefit for severe pediatric bronchial asthma.
Abstract:
40 children with clinical diagnosis of bronchial asthma aged 8--14 years, 39 with allergic disposition, were investigated. Acute therapeutic and protective effect on frequency of asthmatic attacks, pulmonary auscultation and lung function (FEV1, PF, FVC) by application of Fenoterol and Ipratropium as combination aerosol were registered. Over a period of 4 weeks we could reduce the frequency of attacks nearly to the half. 10 and 20 minutes after aerosol application we showed a good improvement of pulmonary ventilation. Only on children with severe asthma bronchiale an exclusive treatment with Berodual seems to be of modest protective effect.